— Know what they know.
Not Investment Advice
Also trades as: ROG.SW (SIX) · $vol 444M · ROP.SW (SIX) · $vol 437M · RHHBY (OTC) · $vol 112M · RO.SW (SIX) · $vol 13M · 0QQ6.L (LSE) · $vol 2M · RHHBF (OTC) · $vol 0M · ROG.TO (TSX) · $vol 0M

RHHVF OTC

Roche Holding AG
1W: +1.2% 1M: +8.1% 3M: +8.5% YTD: +19.0% 1Y: +49.5% 3Y: +67.9% 5Y: +41.3%
$480.61
+10.55 (+2.24%)
 
Weekly Expected Move ±5.7%
$429 $457 $484 $512 $540
OTC · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 72 · $331.1B mcap · 565M float · 0.0008% daily turnover · Short 34% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 10.3% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $5.56 (down 99%), Roche Holding AG would be worth roughly what it owes.
Total debt $38.17B against a stock market value of $331.10B.
Distance to default 7.27 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.04B (short-term plus half of long-term), stock volatility 39.7%; Altman Z'' 3.76. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Cash Flow Trends

Operating Cash Flow
$17.8B -11.2% ▼
5Y CAGR: -0.8%
Capital Expenditures
$3.7B +25.1% ▲
5Y CAGR: -10.9%
Free Cash Flow
$14.1B -6.6% ▼
5Y CAGR: +3.5%
Dividends Paid
$8.4B -9.7% ▼
Buybacks
$987M +12.6% ▲
Net Change in Cash
-$507M -131.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$14.9B$13.5B$12.4B$9.2B$12.9B
Depreciation & Amort.$4.4B$3.8B$3.5B$3.4B$0
Stock-Based Comp.$663M$738M$830M$855M$0
Change in Working Capital-$994M-$2.4B-$1.1B$1.2B-$1.7B
Other Non-Cash Items$722M$4.4B$550M$5.5B$6.6B
Operating Cash Flow$21.0B$18.4B$16.1B$20.1B$17.8B
— Investing Activities —
Capital Expenditures-$4.5B-$4.6B-$3.7B-$3.5B-$5.8B
Acquisitions (Net)-$2.3B$1M$1M-$2.8B-$2.9B
Investment Purchases-$201M-$271M-$832M-$5.2B-$263M
Investment Sales$564M$1.4B$125M$198M$295M
Other Investing-$115M-$112M-$6.2B-$31M-$40M
Investing Cash Flow-$6.6B-$3.5B-$10.6B-$11.4B-$8.7B
— Financing Activities —
Net Debt Issuance$16.7B-$5.7B$5.8B$3.8B-$155M
Stock Repurchased-$19.0B-$1.3B$0$0-$987M
Dividends Paid-$7.8B-$7.4B-$7.6B-$7.7B-$8.4B
Other Financing-$1.7B-$1.9B-$1.3B-$1.9B-$652M
Financing Cash Flow-$13.1B-$16.3B-$4.2B-$6.8B-$10.2B
Net Change in Cash$1.1B-$1.9B$385M$1.6B-$507M
Cash End of Period$6.8B$5.0B$5.4B$7.0B$5.6B
Free Cash Flow$16.4B$13.9B$11.4B$15.1B$14.1B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms